Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

Psychopharmacology

Volumn 200, Issue 4, 2008, Pages 573-583

  Daumann, Jörg ^a   Heekeren, Karsten ^a   Neukirch, Anna ^a   Thiel, Christiane M ^b   Möller Hartmann, Walter ^a   Gouzoulis Mayfrank, Euphrosyne ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Dimethyltryptamine; Experimental psychosis; Inhibition of return; Ketamine; Orienting of attention; Pharmacological fMRI

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N,N DIMETHYLTRYPTAMINE; PLACEBO; PSYCHEDELIC AGENT; SEROTONIN 2A AGONIST;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BLOOD OXYGENATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INHIBITION (PSYCHOLOGY); INHIBITION OF RETURN; MALE; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SPATIAL ORIENTATION;

ADULT; ATTENTION; CROSS-OVER STUDIES; CUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; N,N-DIMETHYLTRYPTAMINE; PSYCHOSES, SUBSTANCE-INDUCED; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL DETECTION, PSYCHOLOGICAL; TASK PERFORMANCE AND ANALYSIS;

EID: 52649124314     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1237-1     Document Type: Article

References (74)

1. KM Abel MP Allin K Kucharska-Pietura C Andrew S Williams AS David ML Phillips 2003 Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in cognitive state Hum Brain Mapp 18 135 145
2. WM Abi-Saab DC D'Souza B Moghaddam JH Krystal 1998 The NMDA antagonist model for schizophrenia: promise and pitfalls Pharmacopsychiatry 31 Suppl 2 104 109
3. J Addington D Addington 1998 Visual attention and symptoms in schizophrenia: a 1-year follow-up Schizophr Res 34 95 99
4. American Psychiatric Association (APA) (1994) DSM-IV: diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC
5. Andreasen NC (1983) The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa, Iowa City, IA
6. Andreasen NC (1984) The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa, Iowa City, IA
7. V Arolt HM Teichert D Steege R Lencer W Heide 1998 Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters Biol Psychiatry 44 448 458
8. NG Burdett DK Menon TA Carpenter JG Jones LD Hall 1995 Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results Magn Reson Imaging 13 549 553
9. WT Carpenter 1999 The schizophrenia ketamine challenge study debate Biol Psychiatry 46 1081 1091
10. CS Carter LC Robertson MR Chaderjian LJ Celaya TE Nordahl 1992 Attentional asymmetry in schizophrenia: controlled and automatic processes Biol Psychiatry 31 909 918
11. CS Carter LC Robertson MR Chaderjian L O'Shora-Celaya TE Nordahl 1994 Attentional asymmetry in schizophrenia: the role of illness subtype and symptomatology Prog Neuropsychopharmacol Biol Psychiatry 18 661 683
12. 2a receptor and the pathology of schizophrenia: a likely accomplice J Neurochem 85 1 13
13. A Dittrich S von Arx S Staub 1985 International study on altered states of consciousness (ISASC). Summary of the results Ger J Psychol 9 319 339
14. DC D'Souza RM Berman JH Krystal DS Charney 1999 Symptom provocation studies in psychiatric disorders: scientific value, risks, and future Biol Psychiatry 46 1060 1080
15. JH Fecteau AH Bell DP Munoz 2004 Neural correlates of the automatic and goal-driven biases in orienting spatial attention J Neurophysiol 92 1728 1737
16. CHY Fu KM Abel MPG Allin D Gasston SG Costafreda J Suckling SC Williams PK McGuire 2005 Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study Psychopharmacology 183 92 102
17. LJ Fuentes E Santiago 1999 Spatial and semantic inhibitory processing in schizophrenia Neuropsychology 13 259 270
18. LJ Fuentes M Boucart R Alvarez AB Vivas MA Zimmerman 1999 Inhibitory processing in visuospatial attention in healthy adults and schizophrenic patients Schizophr Res 40 75 80
19. JM Gold C Randolph R Coppola CJ Carpenter TE Goldberg DR Weinberger 1992 Visual orienting in schizophrenia Schizophr Res 7 203 209
20. E Gouzoulis-Mayfrank L Hermle B Thelen H Sass 1998 History, rationale and potential of experimental hallucinogenic drug research in psychiatry Pharmacopsychiatry 31 S2 63 68
21. E Gouzoulis-Mayfrank M Schreckenberger O Sabri C Arning B Thelen M Spitzer KA Kovar U Büll H Sass 1999 Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG Neuropsychopharmacology 20 565 581
22. E Gouzoulis-Mayfrank K Heekeren T Voss D Moerth B Thelen U Meincke 2004 Blunted inhibion of return (IOR)-a trait marker of schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 28 389 396
23. E Gouzoulis-Mayfrank K Heekeren A Timmerbeil M Stoll C Stock M Obradovic K-A Kovar 2005 Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers Pharmacopsychiatry 38 301 311
24. E Gouzoulis-Mayfrank S Arnold K Heekeren 2006 Deficient inhibition of return in schizophrenia-further evidence from an independent sample Prog Neuropsychopharmacol Biol Psychiatry 30 42 49
25. 2A agonist and NMDA antagonist model of psychosis Neuropsychopharmacology 31 431 441
26. E Gouzoulis-Mayfrank M Balke S Hajsamou S Ruhrmann F Schultze-Luther J Daumann K Heekeren 2007 Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives Schizophr Res 97 35 42
27. T Grunwald H Beck K Lehnertz I Blümcke N Pezer M Kurthen G Fernandez D Van Roost HJ Heinze M Kutas CE Elger 1999 Evidence relating human verbal memory to hippocampal N-methyl-d-aspartate receptors Proc Natl Acad Sci U S A 96 12085 12089
28. PJ Harrison DR Weinberger 2005 Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence Mol Psychiatry 10 40 68
29. PS Holzman 1985 Eye movement dysfunctions and psychosis Int Rev Neurobiol 27 179 205
30. GD Honey RAE Honey SR Sharar DC Turner E Pomarol-Clotet D Kumaran JS Simons X Hu MD Rugg ET Bullmore PC Fletcher 2004 Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of subsequent retrieval task Psychopharmacology 181 445 457
31. RAE Honey GD Honey C O'Loughlin SR Sharar D Kumaran ET Bullmore DK Menon T Donovan VC Lupson R Bisbrown-Chippendale PC Fletcher 2005 Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an fMRI study Neuropsychopharmacology 29 1203 1214
32. J Horacek V Bubenikova-Valesova M Kopecek T Palenicek C Dockery P Mohr C Hoschl 2006 Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia CNS Drugs 20 389 409
33. ED Huey BE Wexler 1994 Abnormalities in rapid, automatic aspects of attention in schizophrenia: blunted inhibition of return Schizophr Res 14 57 63
34. HE Hulshoff Pol HG Schnack RC Mandl W Cahn DL Collins AC Evans RS Kahn 2004 Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity NeuroImage 21 27 35
35. DC Javitt SR Zukin 1991 Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1301 1308
36. S Kapur P Seeman 2002 NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia Mol Psychiatry 7 837 844
37. JS Kim HH Kornhuber W Schmid-Burgk B Holzmüller 1980 Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 20 379 382
38. RM Klein 2000 Inhibition of return Trends Cogn Sci 4 138 147
39. C Konradi S Heckers 2003 Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment Pharmacol Ther 97 153 179
40. JH Krystal LP Karper JP Seibyl GK Freeman R Delaney JD Bremner GR Heninger MB Bowers DS Charney 1994 Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humansPsychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 199 214
41. A Larrison-Faucher KA Briand AB Sereno 2002 Delayed onset of inhibition of return in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 26 505 512
42. J Lepsien S Pollmann 2002 Covert reorienting and inhibition of return: an event-related fMRI study J Cogn Neurosci 14 127 144
43. M Liotti S Dazzi C Umilta 1993 Deficits of the automatic orienting of attention in schizophrenic patients J Psychiatr Res 27 119 130
44. P Maruff J Danckert C Pantelis J Currie 1998 Saccadic and attentional abnormalities in patients with schizophrenia Psychol Med 28 1091 1100
45. AR Mayer JM Dorflinger SM Rao M Seidenberg 2004 Neural networks underlying endogenous and exogenous visual-spatial orienting NeuroImage 23 534 541
46. AR Mayer M Seidenberg JM Dorflinger SM Rao 2004 An event-related fMRI study of exogenous orienting: supporting evidence for the cortical basis of inhibition of return? J Cogn Neurosci 16 1262 1271
47. A Meyer-Lindenberg JB Poline PD Kohn JL Holt MF Egan DR Weinberger KF Berman 2001 Evidence for abnormal cortical functional connectivity during working memory in schizophrenia Am J Psychiatry 158 1809 1817
48. B Moghaddam B Adams A Verma D Daly 1997 Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 2921 2927
49. NG Müller A Kleinschmidt 2007 Temporal dynamics of the attentional spolight: neuronal correlates of attentional capture and inhibition of return in early visual cortex J Cogn Neurosci 19 587 593
50. G Northoff A Richter F Bermpohl S Grimm E Martin VL Marcar C Wahl D Hell H Boeker 2005 NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI Schizophr Res 72 235 248
51. M Oie BR Rund K Sundet 1998 Covert visual attention in patients with early-onset schizophrenia Schizophr Res 34 195 205
52. JE Overall DR Gorham 1962 The brief psychiatric rating scale Psychol Rep 10 799 812
53. Øye N, Hustveit O, Moberg ER, Pausen O, Skoglund LA (1991) The chiral forms of ketamine as probes for NMDA receptor function in humans. In: Kameyama T, Nabeshima T, Domino ES (eds) NMDA receptor related agents: biochemistry, pharmacology and behavior. Ann Arbor, NPP Books, pp 381-389
54. N Øye O Paulsen A Maurset 1992 Effects of ketamine on sensory perception: evidence for a roel of N-methyl-d-aspartate receptors J Pharmacol Exp Ther 260 1209 1213
55. Posner MI, Cohen Y (1984) Components of visual orienting. In: Bouma H, Bouwhuis DG (eds) Attention and performance. Control of language processing. Erlbaum, London, pp 531-556
56. MI Posner TS Early E Reiman PJ Pardo M Dhawan 1988 Asymmetries in hemispheric control of attention in schizophrenia Arch Gen Psychiatry 45 814 821
57. RD Rafal PA Calabresi CW Brennan TK Sciolto 1989 Saccade preparation inhibits reorienting to recently attended locations J Exp Psychol Hum Percept Perform 15 4 673 685
58. JD Ragland RC Gur J Valdez BI Turetsky M Elliott C Kohler S Siegel S Kanes RE Gur 2004 Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia Am J Psychiatry 161 1004 1015
59. AC Rosen SM Rao P Caffarra A Scaglioni JA Bobholz SJ Woodley TA Hammeke JM Cunningham TE Prieto JR Binder 1999 Neural basis of endogenous and exogenous spatial orienting. A functional MRI study J Cogn Neurosci 11 135 152
60. A Sapir N Soroker A Berger A Henik 1999 Inhibition of return in spatial attention: direct evidence for collicular generation Nat Neurosci 2 1053 1054
61. A Sapir A Henik M Dobrusin EY Hochman 2001 Attentional asymmetry in schizophrenia: disengagement and inhibition of return deficits Neuropsychology 15 361 370
62. R Schlosser T Gesierich B Kaufmann G Vucurevic S Hunsche J Gawehn P Stoeter 2003 Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling NeuroImage 19 751 763
63. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkotter J (2007) Schizophrenia proneness instrument, adult version (SPI-A). Giovanni Fioriti Editore s.r.l, Rome, Italy
64. AB Sereno PS Holzman 1995 Antisaccades and smooth pursuit eye movements in schizophrenia Biol Psychiatry 37 394 401
65. SH Snyder 1988 Psychotogenic drugs as models for schizophrenia Neuropsychopharmacology 1 197 199
66. RJ Strassman CR Qualls EH Uhlenhuth R Kellner 1994 Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch Gen Psychiatry 51 98 108
67. ME Strauss T Novakovic AY Tien F Bylsma GD Pearlson 1991 Disengagement of attention in schizophrenia Schizophr Res 37 139 146
68. ME Strauss L Alphs J Boekamp 1992 Disengagement of attention in chronic schizophrenia Psychiatry Res 43 87 92
69. Talairach J, Tournaoux P (1988) Co-planar stereotactic atlas of the human brain. Thieme, Stuttgart
70. G Tsai JT Coyle 2002 Glutamatergic mechanisms in schizophrenia Annu Rev Pharmacol Toxicol 42 165 179
71. FX Vollenweider A Antonini KL Leenders I Oye D Hell J Angst 1997 Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) Eur Neuropsychopharmacol 7 25 38
72. FX Vollenweider P Vontobel I Oye D Hell KL Leenders 2000 Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans J Psychiatr Res 34 35 43
73. DR Weinberger KF Berman RF Zec 1986 Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence Arch Gen Psychiatry 43 114 124
74. DR Weinberger MF Egan A Bertolino JH Callicott VS Mattay BK Lipska KF Berman TE Goldberg 2001 Prefrontal neurons and the genetics of schizophrenia Biol Psychiatry 50 825 844